These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25538088)

  • 1. Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood.
    Melotte V; Yi JM; Lentjes MH; Smits KM; Van Neste L; Niessen HE; Wouters KA; Louwagie J; Schuebel KE; Herman JG; Baylin SB; van Criekinge W; Meijer GA; Ahuja N; van Engeland M
    Cancer Prev Res (Phila); 2015 Feb; 8(2):157-64. PubMed ID: 25538088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia.
    Papadia C; Louwagie J; Del Rio P; Grooteclaes M; Coruzzi A; Montana C; Novelli M; Bordi C; de' Angelis GL; Bassett P; Bigley J; Warren B; Atkin W; Forbes A
    Inflamm Bowel Dis; 2014 Feb; 20(2):271-7. PubMed ID: 24280874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis.
    Bagheri H; Mosallaei M; Bagherpour B; Khosravi S; Salehi AR; Salehi R
    J Gene Med; 2020 Aug; 22(8):e3189. PubMed ID: 32196834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stool DNA methylation assays in colorectal cancer screening.
    Kadiyska T; Nossikoff A
    World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
    Sugimachi K; Matsumura T; Shimamura T; Hirata H; Uchi R; Ueda M; Sakimura S; Iguchi T; Eguchi H; Masuda T; Morita K; Takenaka K; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2016 Nov; 23(12):3948-3955. PubMed ID: 27271927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting.
    Chen H; Zucknick M; Werner S; Knebel P; Brenner H
    Clin Cancer Res; 2015 Jul; 21(14):3318-26. PubMed ID: 26015516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field Cancerization in Sporadic Colon Cancer.
    Park SK; Song CS; Yang HJ; Jung YS; Choi KY; Koo DH; Kim KE; Jeong KU; Kim HO; Kim H; Chun HK; Park DI
    Gut Liver; 2016 Sep; 10(5):773-80. PubMed ID: 27114416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
    Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
    Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly sensitive fecal DNA testing of NDRG4 12b methylation is a promising marker for detection of colorectal precancerosis.
    Ji X; Sha J; Qian H; Zhang G; He T; Dang Y
    J BUON; 2021; 26(4):1239-1245. PubMed ID: 34564976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.
    Pedersen SK; Symonds EL; Baker RT; Murray DH; McEvoy A; Van Doorn SC; Mundt MW; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Dekker E; Young GP
    BMC Cancer; 2015 Oct; 15():654. PubMed ID: 26445409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
    Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
    Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Multiplex Bisulfite PCR-Ligase Detection Reaction-Real-Time Quantitative PCR Assay in Interrogating Bioinformatically Identified, Blood-Based Methylation Markers for Colorectal Cancer.
    Bacolod MD; Mirza AH; Huang J; Giardina SF; Feinberg PB; Soper SA; Barany F
    J Mol Diagn; 2020 Jul; 22(7):885-900. PubMed ID: 32407802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.